Calliditas Therapeutics AB Company

Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Industry: Genomic and Epigenominc Instabillity
Headquarters: Sweden

Visit Website
businessdevelopment@calliditas.com
Register and Claim Ownership